Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: POL, AVO

ACEP Condemns United's New Policy to Retroactively Deny Emergency Care


WASHINGTON, June 8, 2021 /PRNewswire/ -- The American College of Emergency Physicians (ACEP) strongly condemns the dangerous decision by UnitedHealthcare to retroactively deny emergency care claims. ACEP firmly believes that the new policy is in direct violation of the federal Prudent Layperson Standard, which requires insurance companies to provide coverage of emergency care based on the presenting symptoms that brought the patient to the emergency department, not the final diagnosis.

According to the Centers for Disease Control and Prevention (CDC), only 3 percent of emergency visits are "nonurgent." With 90 percent of symptoms overlapping between nonurgent and emergent conditions, in many instances, even physicians cannot know if a patient's symptoms require emergency treatment without conducting a comprehensive medical examination. The Prudent Layperson Standard exists to protect patients for this very reason.

"While we're dismayed by United's decision, we are not, unfortunately, surprised to see an insurance company once again try to cut its costs at the expense of necessary patient care," said Mark Rosenberg, DO, MBA, FACEP, president of ACEP. "UnitedHealthcare is expecting patients to self-diagnose a potential medical emergency before seeing a physician, and then punishing them financially if they are incorrect."

The timing of this new policy comes during a pivotal point in the nation's efforts to combat COVID-19 and encourage vaccination. Throughout the pandemic, ACEP and other medical societies have been encouraging the public to not delay medical care, especially in case of an emergency. Scare tactics like this from insurance companies could severely undermine our collective efforts to get the virus under control.

"Over the past year, we've seen the devastating impact of when patients avoid treatment?including worsening health conditions and even death. This new policy will leave millions fearful of seeking medical care, just as we're getting hold of the COVID-19 pandemic and trying to get as many people vaccinated as possible," said Dr. Rosenberg.

The American College of Emergency Physicians (ACEP) is the national medical society representing emergency medicine. Through continuing education, research, public education and advocacy, ACEP advances emergency care on behalf of its 40,000 emergency physician members, and the more than 150 million Americans they treat on an annual basis. For more information, visit www.acep.org and www.emergencyphysicians.org

SOURCE American College of Emergency Physicians (ACEP)


These press releases may also interest you

at 11:50
The "Global Live Events Market (2024 Edition): Analysis By Event Type (Music, Sports, Comedy, and Theater), By Revenue Source, By Age Group, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to...

at 11:31
The FLCCC Alliance today announced Lynne Kristensen will step into the newly created senior director, communications role leading global public relations and media strategy for the organization. She will also oversee the FLCCC's new international...

at 11:30
The OLB Group, Inc., , a diversified Fintech eCommerce merchant services provider and cryptocurrency mining enterprise, announced today that it has received a written letter from Nasdaq, which has determined that for the last 10 consecutive business...

at 10:50
The "India Embedded Finance Business and Investment Opportunities Databook - 75+ KPIs on Embedded Lending, Insurance, Payment, and Wealth Segments - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering. Embedded Finance...

at 09:55
Egon Zehnder, the world's preeminent leadership advisory firm, today announced Francesco Buquicchio as its next CEO. Buquicchio succeeds Edilson Camara, following a strategic leadership transition and succession planning process. Camara, who will...

at 09:30
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Atara...



News published on and distributed by: